Occult hepatitis B virus infection (Q76380039)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14980545%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

review article

1 reference

title

Occult hepatitis B virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14980545%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

1 reference

Jean-Pierre Allain

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14980545%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

publication date

1 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14980545%20AND%20SRC:MED&resulttype=core&format=json

Transfusion Clinique et Biologique

24 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14980545%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14980545%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14980545%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

18-25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14980545%20AND%20SRC:MED&resulttype=core&format=json

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

24 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Occult hepatitis B virus infection and its clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Post-transfusional anti-HCV-negative non-A non-B hepatitis (II) serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Pathogenesis of posttransfusion viral hepatitis in children with β-thalassemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Long-term histologic and virologic outcomes of acute self-limited hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Serum hepatitis B virus DNA in healthy HBsAg-negative Chinese adults evaluated by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

High prevalence of HBV infectivity in blood donors detected by the dot blot hybridisation assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Hepatitis B virus DNA in serum and liver is commonly found in chinese patients with chronic liver disease despite the presence of antibodies to HBsAg

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Molecular epidemiology and variation of hepatitis B in recent immigrant families to Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Hepatitis B virus persistence after recovery from acute viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Persistent viremia after recovery from self-limited acute hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Molecular variants of hepatitis B virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

HBV: amplified and back in the blood safety spotlight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Serological pattern ?anti-HBc alone?: Report on a workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Significance of isolated hepatitis B core antibody in blood donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Significance of isolated hepatitis B core antibody in blood donors from São Paulo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Serological evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Anticore antibody screening of transfused blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Acute hepatitis B infection associated with blood transfusion in England and Wales, 1991-7: review of database.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2003.11.007

10.1016/J.TRACLI.2003.11.007

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14980545%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14980545%20AND%20SRC:MED&resulttype=core&format=json